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In this study we present the results of 105 consecutive patients with pure mitral regurgitation who underwent
surgical treatment. In all patients mitral regurgitation was associated with mitral valve prolapse: 54 patients
underwent mitral valvuloplasty and 51 patients mitral valve replacement.
Clinical assessment and echocardiography were used as follow-up criteria at one year after surgery. After
mitral valvuloplasty, NYHA decreased from 2-7 ±0-8 to 11 +0-7 (P<001) and workload capacity increased
from 65±28% to 96±25% (P<0001); left endsystolic atrial dimension and enddiastolic dimension
decreased from 6-2 ±0-8 to 4-8 ±1-2 cm (?< 0001) and from 7-2 ±1-3 to 5-9 ±0-8 cm (?< 0-01); ventricular
contraction fraction did not change significantly.
After mitral valve replacement, clinical and echocardiographic improvement was significant but less
remarkable than after valvuloplasty; ventricular contraction fraction fell from 39 ± 7% to 29 ±8% in contrast
to patients undergoing mitral valvuloplasty in whom no significant change occurred.
Complications were rare in both groups though only a minority of patients undergoing mitral valvuloplasty
received anticoagulants. We conclude that mitral valvuloplasty in patients with pure mitral regurgitation
associated with mitral valve prolapse gives excellent results, particularly regarding left ventricular function
when compared with the patients after mitral valve replacement.
Introduction operation was assessed by clinical examination and
At our institution, mitral valvuloplasty (M V) was n o n ; i n v ™ v e evaluation. Particular attention was
introduced by Ake Senning in the early nineteen P a i d t 0 echocardiography which has been recently
sixties; the procedure was then almost abandoned demonstrated to be a valid means for the evaluation
during the nineteen seventies favouring mitral valve o f thue Postoperative result in these patients'4^,
replacement (M VR). Since the convincing results of
 u
 T h e rful ts a f t e r M V w e r e t h e n compared with
Carpentier et al™ were published MV regained a ^ o f a comparable group of 51 patients, who
valid place in treatment of our patients with pure underwent m i t r a l v a l v e replacement (MVR
mitral regurgitation b e c a u s e o f P u r e M R a l s o associated with mitral
Mitral valvuloplasty in patients with mitral prolapse(MP) performed by the same surgical team
regurgitation associated with mitral valve prolapse d u n n S t h e s*me t i m e Penod-
(MVP) offers an alternative to mitral valve replace-
ment and may avoid the potential complications of Patients and methods
a prosthetic valve'1'31. We present here the results of
a study of 54 consecutive patients with pure mitral A t o t a l o f 1 0 5 consecutive patients with pure
regurgitation associated with mitral prolapse under- M R associated with MVP underwent heart surgery
going M V with insertion of a Carpentier ring. All b e t w e e n J a n u a r y ' 9 8 3 a n d J a n u a r y 1986- A t o t a l o f
patients were followed for one year and the result of M P a t i e n t s underwent MV whereas 51 patients
underwent MVR. Both procedures were performed
Submitted for publ,cation on 14 October 1986 and in revised form bV t h e same h e a r t Surgeons (M.T. and L.E.). The
9 February 1987. patients were not randomly allocated to MV or to
Address for corresponds Augusto Gallino, Department of MVR; but the Operative procedure was decided On
Medicine, University Hospital, CH-8091 Zurich, Switzerland. by the heart surgeon for each particular patient.
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Table 1 Preoperative clinical, haemodynamic and surgical data
N Age MR
LAorPCW
(v-wave)
(mmHg)
LVEDP
(mmHg)
EF CO CPB
time
AC
time
(min) (min)
MV
MVR
54
51
54±11
58± 10
57 ±14
60±l l
35±15
30± 17
12±6
15±8
56±8
51 ±9
2-4 ±0-6
21 ±0-7
92±28 36± 10
82±24 32±13
MV = mitral valvuloplasty, MVR = mitral valve replacement, MR = mitral regurgitation, LA = left atrial pressure, PCW =
pulmonary capillary wedge pressure, LVEDP = left ventricular enddiastolic pressure, EF = ejection fraction, CO = cardiac
output, CPB = cardiopulmonary bypass, AC = aortic clamp
Table 2 Preoperative and postoperative follow-up obtained by clinical assessment and echocardiography
MV(N=54)
Preoperative
Postoperative
MVR(N = 51)
PTeoperative
Postoperative
NYHA
2-7±0-8
1-1 ±0-7*
2-6±0-7
l-4±0-6*
CTR
0-56 ±007
0-46±0-08*
0-57±005
0-50±006»*
WC (%)
65 ±28
96 ±25*
57±18
89± 14**
LAD (cm)
6-2±0-8
4-8± 1-2*
5-8±l l
4-9±l-2»*
EDD (cm)
7-2±l-3
5-9±0-8*
7-3 ±0-9
5-9±0-9*«
vcf(%)
37±5
35±6
39±7
29 ±8**
af
21
15
16
12
CTR = cardiothoracic ratio, WC = work capacity in % of expected, LAD = left atrial dimension, EDD = left ventricular
enddiastolic dimension, vcf = ventricular contraction fraction, af=atrial fibrillation
*P<00\,**P< 005 when compared to the preoperative values postoperative follow-up time was 11 ± 2 mths and 9 ± 1 -6 mths
for MV and MVR, respectively.
Patients with other concomitant valvular disease or
coronary artery disease as well as patients with
valve calcification were excluded from the study.
MV with insertion of a Carpentier ring was
performed using previously described technique
including leaflet resection, chordal shortening and/
or fenestration'1*21. MVR was performed by the
same surgical team using a mechanical prosthesis in
29 patients and a biological prosthesis in 22 patients.
All patients had preoperative cardiac catheteriz-
ation; preoperative clinical, haemodynamic and
surgical data of the patients with M V as well of the
control group with MVR are given in Table 1.
Preoperative assessment as well as follow-up at 12
months after operation included clinical evaluation
using NYHA criteria, chest X-ray (measurement
of cardiotheracic ratio), ECG and ECG-stress test
for determining the work capacity (WC) and
echocardiography. M-mode echocardiography
(Organon Technika 224 Mfo) and cross-sectional
echocardiography (Diasonics CV 3400 R) with a
standard transducer (2-25 MHz) were performed
for every patient by the same investigator (R.J.).
Left endsystolic atrial dimension (LAD), left
ventricular enddiastolic (EDD) and endsystolic
(ESD) dimensions as well as ventricular contraction
fraction (VCF) were measured for every patient.
In patients with MV, acetylsalisylic acid (ASA),
(1200 mg day"1) was given only in the presence
of atrial fibrillation. Patients with mechanical
MVR received oral anticoagulants postoperatively
whereas patients with biological MVR received
anticoagulants only in the presence of atrial
fibrillation.
The paired Mest was used for comparing the
results before and after operation; Mest was used
for comparing the results between patients with MV
and MVR.
Results
CLINICAL FINDINGS (TABLE 2)
After MV there was a remarkable clinical im-
provement: Clinical symptoms (NYHA), workload
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capacity (WC) and cardiothoracic ratio (CTR)
improved from 2-7±0-8, 65±28% and 0-56±007
to 1-1 ±0-7 (/><001), 96±25% (/><0-001) and
0-46 ± 008 (P < 001), respectively.
After MVR there was also a significant improve-
ment in these clinical parameters but, with the
exception of NYHA, the improvement was less
pronounced than after MV (P<005).
The incidence of atrial fibrillation in patients
after MV was 10/35 (28%) and similar to that in
patients after MVR 7/29 (23%).
ECHOCARDIOGRAPH1C FINDINGS (TABLE 2,
FIGS 1 AND 2)
After M V there was also a major improvement of
left atrial dimension (LAD) and enddiastolic
dimension (EDD) than after MVR: LAD and EDD
fell from 6-2±0-8 and 7-2±l-3 to 4-8± 1-2
(/><001) and 5-9±0-8 (/><001) respectively.
Ventricular contraction fraction (VCF) did not
change significantly after MV; whereas there was a
significant fall in VCF from 39 ±7% to 29 ±8%
(P<005) after MVR.
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Figure I Left atrial dimension (LAD) before and 12 months
after mitral valvuloplasty (MV).
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Figure 2 Left ventricular enddiastolic dimension (EDD)
before and 12 months after mitral valvuloplasty (MV).
Complications
After M V, one death occurred 4 days after oper-
ation in a 72 year old patient because of sudden
death in asystole: there were no other deaths after
MV during the duration of the study. Reoperation
was necessary 4 days after MV because of post-
operative severe subaortic stenosis documented
by echocardiography, angiography and pressure
measurements in one patient without any evidence
of this lesion preoperatively. Transitory ischaemic
attacks (TIA) occurred in four patients reporting
transitory visual disturbance (two patients were on
anticoagulation); in 1 patient with postoperative
atrial fibrillation complete stroke with aphasia and
right hemiparesis occurred under anticoagulation.
In patients with MVR there was also one sudden
death in a 61 year old patient 12 months after
operation: there were 5 patients with TIA and one
patient with a complete stroke.
In one patient, endocarditis occurred 6 months
after MVR (bioprosthesis) and was successfully
treated by medical therapy; no patient developed
endocarditis after MV.
Discussion
Our results show that MV represents a valid and
safe procedure for the treatment of patients with
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pure MV associated with MVP giving excellent
early results which are comparable and even better
than those after MVR particularly regarding left
ventricular function17"9'. Complications and par-
ticularly thromboembolic events after MV were
rare as well as in the control group with MVR
though only a minority of patients undergoing MV
received anticoagulants. The fact that patients were
not randomized to MV or MVR may limit the value
of our results. However, there was no significant
difference in preoperative clinical and haemo-
dynamic findings between the two groups of patients
and in both groups MR was always associated
with MVP giving consistency to our results. The
incidence of postoperative atrial fibrillation was
also similar in both groups of patients.
After MVR ventricular contraction fraction
(VCF) decreased significantly whereas in patients
undergoing MV no deterioration of VCF occurred.
In contrast to MVR, MV allows the preservation of
the continuity between the mitral annulus and left
ventricular wall through the chordae tendinae and
papillary muscles which seem to play an important
role in left ventricular function'101 and may explain
the better outcome in our patients after MV.
Severe subaortic stenosis requiring reoperation
developed in one patient 4 days after MV. This
uncommon complication has been reported
previously1"'21. In our patient haemodynamic
evaluation before and after the myectomy procedure
proved the beneficial effect of reoperation.
Through the number of patients and particularly
the follow-up time are not sufficient to allow a
definite statement, MV seems to represent a valid
operative approach for patients with pure MR
associated with MVP with even better early results
than in patients undergoing MVR. Whether
patients with pure MR not associated with MVP
may also benefit from M V remain questionable; this
will need to be verified by further studies.
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